Sedative and cardiopulmonary effects of intranasal butorphanol with midazolam or dexmedetomidine in New Zealand white rabbits
Veterinary Record · 08.07.2023 · 193 (1)
DOI: 10.1002/vetr.2999 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Record, online erschienen am 14.05.2023. Verfasst von Sitkican Okur und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey. Hauptthemen laut MEDLINE: Hypnotics and Sedatives, Dexmedetomidine. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
This study aimed to compare the sedative and cardiopulmonary effects of intranasal (IN) administration of dexmedetomidine–butorphanol (DB) and midazolam–butorphanol (MB) combinations in New Zealand white rabbits.
Methods
Eight New Zealand white rabbits were sedated by IN administration of a combination of 0.1 mg/kg dexmedetomidine and 0.4 mg/kg butorphanol (DB treatment) and 2 mg/kg midazolam and 0.4 mg/kg butorphanol (MB treatment). The electrocardiogram, pulse rate (PR), respiratory frequency ( f R ), arterial haemoglobin oxygen saturation (SpO 2 ), fraction of expired carbon dioxide (EtCO 2 ), rectal temperature (RT), noninvasive mean arterial pressure (MAP), noninvasive systolic arterial pressure (SAP) and diastolic arterial pressure (DAP) were recorded. The onset of sedation, duration of sedation and sedation score (SS) were also noted.
Results
There were no significant differences in the EtCO 2 , RT, MAP, SAP and DAP measurements between treatments. The PR significantly decreased in DB compared with MB over time ( p = 0.001). Compared with baseline, SpO 2 decreased over time in both treatments. The SS was significantly elevated over time in DB compared with MB ( p = 0.002).
Limitations
No pharmacokinetic information was available for either treatment, so the findings should be interpreted cautiously.
Conclusions
IN DB provides more effective sedation than MB, but cardiopulmonary impairment was observed in both treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
- Department of Surgery, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, Burdur, Turkey.
ORCID-Profile: Sitkican Okur, Latif Emrah Yanmaz, Ayse Golgeli, Mumin Gokhan Senocak, Ugur Ersoz, Omer Tarik Orhun, Burak Gumurcinler
Zitieren
APA
Okur, S., Yanmaz, L. E., Golgeli, A., Senocak, M. G., Ersoz, U., Orhun, O. T., & Gumurcinler, B. (2023). Sedative and cardiopulmonary effects of intranasal butorphanol with midazolam or dexmedetomidine in New Zealand white rabbits. Veterinary Record, 193(1). https://doi.org/10.1002/vetr.2999
Vancouver
Okur S, Yanmaz LE, Golgeli A, Senocak MG, Ersoz U, Orhun OT, et al. Sedative and cardiopulmonary effects of intranasal butorphanol with midazolam or dexmedetomidine in New Zealand white rabbits. Veterinary Record. 2023;193(1). doi:10.1002/vetr.2999
BibTeX
@article{Okur2023,
author = {Okur, Sitkican and Yanmaz, Latif Emrah and Golgeli, Ayse and Senocak, Mumin Gokhan and Ersoz, Ugur and Orhun, Omer Tarik and Gumurcinler, Burak},
title = {Sedative and cardiopulmonary effects of intranasal butorphanol with midazolam or dexmedetomidine in New Zealand white rabbits},
journal = {Veterinary Record},
year = {2023},
volume = {193},
number = {1},
doi = {10.1002/vetr.2999}
}
EUVIMED